F19.9
Other psychoactive substance use, unspecified
Clinical Classification Guidelines
Excludes Type 1
- other psychoactive substance abuse (F19.1-)
- other psychoactive substance dependence (F19.2-)
Medical Intelligence & Overview
ICD-10 code F19.9 refers to cases of psychoactive substance use that do not fall into specific categories. Psychoactive substances are chemicals that affect the brain, leading to changes in mood, perception, consciousness, or behavior. When the precise substance used cannot be identified or specified, this general code is used. It highlights the importance of recognizing substance use issues even when the specific substance remains unknown, ensuring individuals receive appropriate attention and care.
Causes & Symptoms
Clinical Causes: Use of unidentified or unclassified psychoactive substances Experimentation with new or emerging drugs Polydrug use where the primary substances are not noted Lack of detailed documentation or reporting on the specific substance involved Intentional or accidental ingestion of substances not routinely classified
Key Symptoms: Altered mental state, such as confusion or disorientation Changes in mood, including euphoria or anxiety Physical signs like vomiting, tremors, or increased heart rate Behavioral changes like agitation, paranoia, or social withdrawal Potential overdose symptoms, depending on the substance involved
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves clinical assessment, including a personal history of substance use and physical examination. Laboratory tests, such as blood or urine screenings, may be utilized to detect the presence of psychoactive substances. Since the specific substance remains unspecified, healthcare providers focus on presenting symptoms and patterns of behavior to guide diagnosis. It's also important to differentiate between use and dependence, considering the impact on a person’s daily functioning. Proper documentation and thorough history-taking are essential to accurately classify the use under this code.
Treatment Protocols: Detoxification and medical stabilization if necessary Psychosocial interventions such as counseling or therapy, including cognitive-behavioral therapy (CBT) Support groups and peer support programs Addressing underlying mental health issues or co-occurring disorders Education on the risks associated with substance use and relapse prevention Monitoring and follow-up to prevent recurrence and support recovery
Clinical Advice & FAQs
Billing Guidance
Is F19.9 a billable ICD-10 code?
Yes, F19.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.9?
Clinical documentation must specify the nature of Other psychoactive substance use, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference